Robert W. Duggan - Jul 5, 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Stock symbol
PLSE
Transactions as of
Jul 5, 2023
Transactions value $
$289,112
Form type
4
Date filed
7/7/2023, 06:26 PM
Previous filing
Jun 16, 2023
Next filing
Jul 27, 2023

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Stock Option (right to buy) Options Exercise $0 -65K -49.82% $0.00 65.5K Jul 5, 2023 Common Stock 65K $2.14 Direct F2
transaction PLSE Stock Option (right to buy) Options Exercise $0 -65.5K -100% $0.00* 0 Jul 7, 2023 Common Stock 65.5K $2.14 Direct F2
transaction PLSE Stock Option (right to buy) Options Exercise $0 -1.67K -8.33% $0.00 18.3K Jul 7, 2023 Common Stock 1.67K $5.95 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.
F2 All of the shares subject to the option are fully vested and exercisable as of the date hereof.
F3 Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vests on a monthly basis following the Company's last Annual Stockholder Meeting.